A new report titled “Exosomes Diagnostic and Therapeutic Market – Forecast to 2033” by Eternal Markets, the global Exosomes Diagnostic and Therapeutic industry is projected to grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2033, reaching a value of USD 230.3 million by the end of the forecast period.
Overview
The global exosomes diagnostic and therapeutic market is anticipated to experience substantial growth over the forecast period. Exosomes, small extracellular vesicles, play a crucial role in cell communication and are pivotal in various biological processes. They are increasingly recognized for their potential in diagnostics and therapeutics, especially in cancer, neurodegenerative, and cardiovascular diseases. The rising prevalence of these diseases, coupled with advancements in exosome isolation and analysis techniques, drives the market. Additionally, the growing investment in biotechnology and pharmaceutical research enhances the development and application of exosome-based solutions.
Key Visions
- Estimated CAGR of around 11.2% over the forecast period (2024-2033).
- Global Exosomes Diagnostic and Therapeutic Industry size is projected to reach USD 230.3 million by 2033 from USD 84.5 million in 2023.
- Increasing prevalence of chronic diseases and advancements in exosome technology is the key driver for the market.
- By product type, in 2023, the Instruments segment held the largest market share.
- Based on application, the Diagnostics segment is likely to be the largest revenue contributor in 2033.
- North America held the largest market share in 2023 due to advanced healthcare infrastructure, high investment in R&D, and presence of major market players.
Key Market Drivers
Rising Prevalence of Chronic Diseases: Increasing cases of cancer, cardiovascular, and neurodegenerative diseases globally.
Technological Advancements: Continuous advancements in exosome isolation and analysis techniques.
Growing Biotechnology and Pharmaceutical Research: Increased investment and focus on biotech research and development.
Potential in Personalized Medicine: Exosomes’ potential in diagnostics and therapeutics for personalized medicine.
Restraining Factors
Technical Challenges: Challenges related to the standardization and scalability of exosome-based diagnostics and therapies.
Regulatory Hurdles: Stringent regulatory requirements that may delay product approval and market entry.
Limited Awareness: Limited awareness and understanding of exosome technology in certain regions.
Future Scope
Expansion in Therapeutic Applications: Broadening the scope of exosome-based therapies in various medical fields.
Increased Investment: Significant funding and investment in research and development by public and private sectors.
Regulatory Support: Streamlined regulatory frameworks to facilitate quicker approval and commercialization of exosome-based products.
Partnerships and Collaborations: Enhanced collaborations between research institutions and biotech companies to drive innovation and application.
Major Strategies adopted by key market players.
- Agreements, Collaborations, and Partnerships: 32%
- Acquisitions: 14%
- New Product Launch: _%
- Other Developments: _%
Geographical Analysis
Leading Region: North America dominated the exosomes diagnostic and therapeutic market in 2023 due to advanced healthcare infrastructure, high investment in R&D, and presence of major market players.
Growth Potential: Europe shows significant market potential with strong biotech research and healthcare infrastructure. Due to High funding for research, increasing prevalence of chronic diseases, and robust healthcare systems.
Recent Developments
- 2023: Thermo Fisher Scientific launched a new exosome isolation kit with enhanced efficiency.
- 2022: AMS Biotechnology announced a strategic partnership with a major cancer research institute to develop exosome-based diagnostics.
- 2021: Lonza Group (HansaBioMed Life Sciences Ltd.) introduced advanced software for exosome analysis.
- 2020: Capricor Therapeutic made significant advancements in exosome-based cardiac therapy.
Scope of the Report:
Global Exosomes Diagnostic and Therapeutic Market, By Product
- Instruments
- Software
- Reagents and Kits
Global Exosomes Diagnostic and Therapeutic Market, By Application
Global Exosomes Diagnostic and Therapeutic Market, By End User
- Hospitals
- Cancer Institutes
- Diagnostic Centers
- Others
Global Exosomes Diagnostic and Therapeutic Market, by Geography
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
● Thermo Fisher Scientific
● AMS Biotechnology
● Miltenyi Biotec
● NX Pharmagen
● Lonza Group (HansaBioMed Life Sciences Ltd.)
● Malvern Instruments
● NanoSomix
● Capricor Therapeutic
● Exosome Diagnostics
● Exiqon A/S
● System Biosciences
● Exosome Sciences
● Aegle Therapeutic
● Codiak BioSciences Inc.
● AcouSort AB
● Other key players
*The report scope shall be customized as per the requirements
Chapter 1 Global Exosomes Diagnostic and Therapeutic Market Overview
1.1 Introduction
1.2 Drivers for Exosomes Diagnostic and Therapeutic Market
1.3 Restraints for Exosomes Diagnostic and Therapeutic Market
1.4 Opportunities for Exosomes Diagnostic and Therapeutic Market
1.5 Trends for Exosomes Diagnostic and Therapeutic Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Exosomes Diagnostic and Therapeutic Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Thermo Fisher Scientific
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 AMS Biotechnology
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Miltenyi Biotec
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 NX Pharmagen
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Lonza Group (HansaBioMed Life Sciences Ltd.)
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Malvern Instruments
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 NanoSomix
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Capricor Therapeutic
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Exosome Diagnostics
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Exiqon A/S
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Exosomes Diagnostic and Therapeutic Market Overview
3.1 Global Exosomes Diagnostic and Therapeutic Market Outlook (2017-2032)
3.1.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Exosomes Diagnostic and Therapeutic Market by Region
3.2.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Exosomes Diagnostic and Therapeutic Market by Product
3.3.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
3.3.2 Global Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Product, 2023–2032
3.3.3 Global Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Exosomes Diagnostic and Therapeutic Market by End User
3.4.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
3.4.2 Global Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by End User, 2023–2032
3.5 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Product
3.6.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
3.6.2 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
3.7 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
3.7.2 Global Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
3.8 Global Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Region
3.8.2 Global Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Product
3.8.3 Global Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by End User
3.9 Global Exosomes Diagnostic and Therapeutic Market Share Comparison 2017–2032
3.9.1 Global Exosomes Diagnostic and Therapeutic Market Share by Region
3.9.2 Global Exosomes Diagnostic and Therapeutic Market Share by Product
3.9.3 Global Exosomes Diagnostic and Therapeutic Market Share by End User
Chapter 4 North America Exosomes Diagnostic and Therapeutic Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Exosomes Diagnostic and Therapeutic Market Outlook (2017-2032)
4.2.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Exosomes Diagnostic and Therapeutic Market by Region
4.3.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Exosomes Diagnostic and Therapeutic Market by Product
4.4.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
4.4.2 North America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Product, 2023–2032
4.4.3 North America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Exosomes Diagnostic and Therapeutic Market by End User
4.5.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
4.5.2 North America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by End User, 2023–2032
4.6 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Product
4.7.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
4.7.2 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
4.8 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by End User
4.8.1 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
4.8.2 North America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
4.9 North America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Region
4.9.2 North America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Product
4.9.3 North America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by End User
4.1 North America Exosomes Diagnostic and Therapeutic Market Share Comparison 2017–2032
4.10.1 North America Exosomes Diagnostic and Therapeutic Market Share by Region
4.10.2 North America Exosomes Diagnostic and Therapeutic Market Share by Product
4.10.3 North America Exosomes Diagnostic and Therapeutic Market Share by End User
Chapter 5 Europe Exosomes Diagnostic and Therapeutic Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Exosomes Diagnostic and Therapeutic Market Outlook (2017-2032)
5.2.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Exosomes Diagnostic and Therapeutic Market by Region
5.3.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Exosomes Diagnostic and Therapeutic Market by Product
5.4.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
5.4.2 Europe Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Product, 2023–2032
5.4.3 Europe Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Exosomes Diagnostic and Therapeutic Market by End User
5.5.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
5.5.2 Europe Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by End User, 2023–2032
5.6 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Product
5.7.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
5.7.2 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
5.8 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by End User
5.8.1 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
5.8.2 Europe Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
5.9 Europe Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Region
5.9.2 Europe Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Product
5.9.3 Europe Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by End User
5.1 Europe Exosomes Diagnostic and Therapeutic Market Share Comparison 2017–2032
5.10.1 Europe Exosomes Diagnostic and Therapeutic Market Share by Region
5.10.2 Europe Exosomes Diagnostic and Therapeutic Market Share by Product
5.10.3 Europe Exosomes Diagnostic and Therapeutic Market Share by End User
Chapter 6 Asia Pacific Exosomes Diagnostic and Therapeutic Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Outlook (2017-2032)
6.2.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Exosomes Diagnostic and Therapeutic Market by Region
6.3.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Exosomes Diagnostic and Therapeutic Market by Product
6.4.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
6.4.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Product, 2023–2032
6.4.3 Asia Pacific Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Exosomes Diagnostic and Therapeutic Market by End User
6.5.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
6.5.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by End User, 2023–2032
6.6 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Product
6.7.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
6.7.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
6.8 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by End User
6.8.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
6.8.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
6.9 Asia Pacific Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Product
6.9.3 Asia Pacific Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by End User
6.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Share Comparison 2017–2032
6.10.1 Asia Pacific Exosomes Diagnostic and Therapeutic Market Share by Region
6.10.2 Asia Pacific Exosomes Diagnostic and Therapeutic Market Share by Product
6.10.3 Asia Pacific Exosomes Diagnostic and Therapeutic Market Share by End User
Chapter 7 South America Exosomes Diagnostic and Therapeutic Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Exosomes Diagnostic and Therapeutic Market Outlook (2017-2032)
7.2.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Exosomes Diagnostic and Therapeutic Market by Region
7.3.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Exosomes Diagnostic and Therapeutic Market by Product
7.4.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
7.4.2 South America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Product, 2023–2032
7.4.3 South America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Exosomes Diagnostic and Therapeutic Market by End User
7.5.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
7.5.2 South America Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by End User, 2023–2032
7.6 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Product
7.7.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
7.7.2 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
7.8 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by End User
7.8.1 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
7.8.2 South America Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
7.9 South America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Region
7.9.2 South America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Product
7.9.3 South America Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by End User
7.1 South America Exosomes Diagnostic and Therapeutic Market Share Comparison 2017–2032
7.10.1 South America Exosomes Diagnostic and Therapeutic Market Share by Region
7.10.2 South America Exosomes Diagnostic and Therapeutic Market Share by Product
7.10.3 South America Exosomes Diagnostic and Therapeutic Market Share by End User
Chapter 8 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Outlook (2017-2032)
8.2.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Exosomes Diagnostic and Therapeutic Market by Region
8.3.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Exosomes Diagnostic and Therapeutic Market by Product
8.4.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2032)
8.4.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Product, 2023–2032
8.4.3 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Exosomes Diagnostic and Therapeutic Market by End User
8.5.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
8.5.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Attractiveness Analysis by End User, 2023–2032
8.6 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by Product
8.7.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2017-2023)
8.7.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by Product (2024-2032)
8.8 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) by End User
8.8.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
8.8.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
8.9 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by Product
8.9.3 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Y-o-Y Growth Rate by End User
8.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Share by Region
8.10.2 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Share by Product
8.10.3 Middle East and Africa Exosomes Diagnostic and Therapeutic Market Share by End User
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
